News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,839 Results
Type
Article (8016)
Company Profile (141)
Press Release (477951)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166741)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238193)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (491)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33156)
ALS (112)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (285)
Approvals (10418)
Artificial intelligence (336)
ASCO (159)
Autoimmune disease (221)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6958)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (1)
Bladder cancer (140)
Brain cancer (31)
Breast cancer (521)
Cancer (3774)
Cardiovascular disease (227)
Career advice (245)
Career pathing (1)
CAR-T (178)
CDC (1)
CDMO (19)
Celiac Disease (1)
Cell therapy (489)
Cervical cancer (35)
Clinical research (48062)
Collaboration (1282)
Commercialization (3)
Compensation (1538)
Complete response letters (34)
COVID-19 (762)
CRISPR (64)
C-suite (807)
Cystic fibrosis (87)
Data (5876)
Denatured (4)
Depression (107)
Dermatology (68)
Diabetes (357)
Diagnostics (4222)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (160)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73749)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88135)
Executive appointments (714)
FDA (12510)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (950)
Gene editing (126)
Generative AI (11)
Gene therapy (335)
GLP-1 (294)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9369)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (108)
Immuno-oncology (61)
Indications (164)
Infectious disease (954)
Inflammatory bowel disease (129)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (262)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (19)
Liver cancer (45)
Longevity (19)
Lung cancer (547)
Lymphoma (258)
Machine learning (29)
Management (3)
Manufacturing (571)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8682)
Medtech (8841)
Mergers & acquisitions (14411)
Metabolic disorders (730)
mRNA (64)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (228)
Neuropsychiatric disorders (40)
Neuroscience (1879)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (232)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (207)
Parkinson's disease (206)
Partnered (12)
Patents (500)
Patient recruitment (531)
Patient selection (2)
Peanut (32)
People (41367)
Peptides (3)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15521)
Phase 2 (21461)
Phase 3 (14473)
Pipeline (7733)
Policy (18)
Postmarket research (1570)
Preclinical (6555)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (590)
Real estate (3023)
Recruiting (6)
Regenerative medicine (2)
Regulatory (14981)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (104)
Series A (165)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2021)
Stomach cancer (3)
Supply chain (51)
Vaccines (335)
Venture capital (17)
Weight loss (75)
Women's health (89)
Date
Today (71)
Last 7 days (265)
Last 30 days (1447)
Last 365 days (19090)
2026 (13742)
2025 (19239)
2024 (22986)
2023 (26529)
2022 (34587)
2021 (37168)
2020 (33470)
2019 (23239)
2018 (17461)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20426)
2010 (20332)
Location
Africa (227)
Alabama (78)
Alaska (2)
Arizona (311)
Arkansas (10)
Asia (17945)
Australia (2093)
California (12368)
Canada (3247)
China (548)
Colorado (499)
Connecticut (427)
Delaware (215)
Europe (24631)
Florida (1862)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (730)
India (51)
Indiana (324)
Iowa (16)
Japan (428)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1232)
Massachusetts (8118)
Michigan (315)
Minnesota (573)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (123)
New Hampshire (60)
New Jersey (2707)
New Mexico (12)
New York (2903)
North Carolina (1318)
North Dakota (4)
Northern California (6220)
Ohio (296)
Oklahoma (14)
Oregon (16)
Pennsylvania (2300)
Puerto Rico (21)
Rhode Island (30)
South America (402)
South Carolina (78)
South Dakota (1)
Southern California (5151)
Tennessee (125)
Texas (2015)
United States (40118)
Utah (375)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (957)
West Virginia (1)
Wisconsin (75)
Wyoming (1)
485,839 Results for "minnetronix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Intricon becomes Forj Medical and Announces Opening Plans for its Advanced Manufacturing Facility in Costa Rica
Intricon completes construction of its Evolution Free Zone location, combines with Minnetronix Medical, and will fly the Forj Medical flag at its new site; equipment and workforce move into place for the grand opening
December 9, 2025
·
1 min read
Sona Nanotech Selects Minnetronix to Engineer Its Next Generation Targeted Hypothermia Cancer Therapy Light Device
Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”), a nanotechnology company developing pre-clinical Targeted Hyperthermia Therapy for colorectal cancer, is pleased to announce the selection of Minnetronix Medical to engineer the second generation of its infrared light device.
June 16, 2023
·
3 min read
Business
Eyevensys Enters Collaboration with Phillips-Medisize and Minnetronix Medical
Eyevensys today announces it has entered into strategic engagements with US-based medical device manufacturers Phillips-Medisize and Minnetronix Medical to develop the next generation of the company’s core technology.
September 27, 2021
·
5 min read
BioMidwest
Minnetronix Announces Rebrand to Minnetronix Medical
Minnetronix, Inc. , a leading medical technology and solutions provider, today announced that it has rebranded as Minnetronix Medical, Inc.
September 10, 2018
·
2 min read
Sona Nanotech Selects Minnetronix to Engineer Its Next Generation Targeted Hyperthermia Cancer Therapy Light Device
Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”), a nanotechnology company developing pre-clinical Targeted Hyperthermia Therapy (“THT”) for colorectal cancer
May 30, 2023
·
4 min read
Business
Minnetronix Medical Names Jeremy Maniak President and CEO
Minnetronix Medical, Inc., a leading medical technology company, announced that the company’s President, Jeremy Maniak, will succeed founder Richard Nazarian as CEO on February 1, 2020.
November 4, 2019
·
1 min read
BioMidwest
Minnetronix Medical Gets FDA Clearance on Innovative Neurosurgical Access Platform
Minnetronix Medical, the company known for 25 years of developing and manufacturing products for medical device companies throughout the world, today announced that it has received FDA clearance for its first platform product: the MindsEye™ Expandable Port for neurosurgical procedures.
September 9, 2020
·
2 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
1 of 48,584
Next
